Why the study?
CRT improves morbidity and mortality in chronic HF, and optimal medical therapy is critical for prognosis and quality of life, but pharmacological treatment changes after CRT need evaluation.
Does pharmacological treatment change in heart failure patients during a 1-year follow-up after CRT implantation?
Does pharmacological treatment change in heart failure patients during a 1-year follow-up after CRT implantation?
CRT implantation in heart failure patients is associated with an increase in the prescription rates of beta-blockers and diuretics, as well as an overall increase in the number of cardiovascular medications at 1-year follow-up.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Laukaitienė et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: